Kathryn S. Crawford

Vice President, Regulatory and Quality

About

Specialties: Preclinical development and strategic program planning, including efficacy models and regulatory toxicology. 20+ years experience pharmaceutical development, specializing in ophthalmics and preclinical models for ocular disease

Country

United States

City

Andover

Industry

Pharmaceuticals

Skill

Communication, Strategic Planning, Leadership, Pharmacology, Pharmacokinetics, IND, Pharmaceutical Research, Pharmaceutical Development, Toxicology, GLP, Regulatory Submissions, Translational Medicine, Drug Delivery, R&D, Ophthalmic, Ocular, Animal Models, Preclinical, Glaucoma, Ocular Allergy

Experience

Vice President, Regulatory and Quality

Amorphex Therapeutics, LLC

2017-10 - Present · 9 yrs

Greater Boston Area

VP, Head Preclinical Development

Allysta Pharmaceuticals

2017-1 - Present · 9 yrs 9 mos

CEO

PharmOcu, LLC

2005 - Present · 21 yrs

Boston, MA

Pharmaceutical Development Consulting Strategic guidance on early stage and preclinical development programs, accelerating proof-of-concept through regulatory submissions, including preclinical efficacy models, toxicology, formulation, manufacturing, project management, compliant documentation, and funding. Specialization in SBIR application process, early stage ophthalmic drug development, ocular drug delivery. www.pharmocu.com